BC Innovations | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

New Therapeutic Targets and Biomarkers: October 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during October 2017. Therapeutic targets are defined as any protein, gene or other...
BC Innovations | Oct 24, 2017
Distillery Therapeutics

Infectious disease; hepatic

INDICATION: Sepsis; liver disease Patient sample and mouse studies suggest inhibiting NMI could help treat sepsis and liver injury, and inhibiting IFI35 could help treat sepsis. In serum samples from sepsis patients, NMI levels were...
BC Extra | May 13, 2016
Top Story

White House launches National Microbiome Initiative

On Friday, the White House Office of Science and Technology Policy (OSTP) announced the National Microbiome Initiative (NMI), which will seek to enhance the understanding of microbiome behavior and promote healthy microbiome function. The initiative,...
BC Week In Review | Feb 13, 2006
Company News

Luminex scientific advisory board update

Luminex Corp. (LMNX), Austin, Texas   Business: Supply/Service   Appointed: James Jacobson, LMNX's VP of R&D; C. Thomas Caskey, COO of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases; Ronald...
BC Week In Review | Nov 15, 1999
Company News

Geneka Biotechnology Inc., Nova Molecular Inc. deal

The companies will use Geneka’s gene expression technology to identify transcription factors involved in membrane remodeling pathways for neuron repair that Nova is targeting to treat central nervous system diseases such as Alzheimer’s disease. The...
BioCentury | Apr 15, 1996

Awash in shares

Other than the decline in stock prices, last week's big news was the announcement of two six-million share follow-on offerings. Seattle-based ICOS Corp. (ICOS) hired five investment firms to co-manage a six million-share offering (about...
Items per page:
1 - 6 of 6